Alternative strategies
Carmignac Absolute Return Europe
Share Class
FR0010149179
Risk Indicator
3 / 7
Recommended Minimum Investment Horizon
3 years
Cumulative Performance since launch
Cumulative Performance 10 YearsCumulative Performance 5 YearsCumulative Performance 3 YearsCumulative Performance 12 Months
From 02/01/2003
To 13/02/2025
+ 137.7 %
+ 33.7 %
+ 13.1 %
+ 0.1 %
+ 1.9 %
Calendar Year Performance 2015Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023Calendar Year Performance 2024
- 8.0 %
+ 8.9 %
+ 14.6 %
+ 4.4 %
- 1.3 %
+ 5.2 %
+ 12.6 %
- 6.4 %
0.0 %
+ 3.6 %
Net Asset Value
429.38 €
Asset Under Management
190 M €
Market
European market
SFDR - Fund Classification
Article 8
Portfolio Composition
Discover the Fund's portfolio and allocation to get an overview of the distribution of its investments, to better understand its strategy, diversification and risk exposure.
Key figures
Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.Exposure Data
Data as of: 31 Jan 2025.Equity Investment Weight97.1 %
Net Equity Exposure32.6 %
Number of Equity Issuers56
Active Share50.0 %
TOP 10 Fund Positions
The main positions of Fund are classified according to their weighting and expressed as a percentage of the Fund's total assets.Top Ten - Equities
Data as of: 31 Jan 2025.| DEUTSCHE TELEKOM AG |  Germany | Communication Services | 2.9% |
| META PLATFORMS INC |  USA | Communication Services | 2.7% |
| FRESENIUS SE & CO KGAA | Germany | Healthcare | 2.6% |
| MICROSOFT CORP | USA | Information Technology | 2.6% |
| EURONEXT NV |  Netherlands | Financials | 2.4% |
| SAP SE | Germany | Information Technology | 2.0% |
| AIR LIQUIDE SA |  France | Materials | 1.7% |
| UCB SA |  Belgium | Healthcare | 1.7% |
| RELX PLC |  United Kingdom | Industrials | 1.6% |
| LONZA GROUP AG |  Switzerland | Healthcare | 1.6% |
Total
21.9 %
Top 10 Short Positions
Data as of: 31 Jan 2025.Geographical Breakdown
The Fund’s exposure to specific country and region provides you with an insight on its diversification as well as the opportunities and risks involved. The geographic breakdown also provides an overview of the Fund's investment strategy and current positioning.Geographical Breakdown
Data as of: 31 Jan 2025.| North America | 20.9 % | -9.2 % | 11.8 % |
| Others | 7.3 % | -5.0 % | 2.4 % |
| Europe EUR | 83.7 % | -55.5 % | 28.1 % |
| Europe ex-EUR | 25.1 % | -12.9 % | 12.3 % |
| Index Derivatives | 9.1 % | -31.1 % | -21.9 % |
North America11.8 %
 Canada | 0.9 % | - |
| USA | 20.0 % | -9.2 % |
Sector Breakdown
The Fund’s exposure to specific sector provides you with an insight on its diversification as well as the opportunities and risks involved. The sector breakdown also provides an overview of the Fund's investment strategy and current positioning.
Sector Breakdown
Data as of: 31 Jan 2025.Equity Exposure
The chart displays the proportion of the Fund's assets invested in equities and how this exposure has changed over time. It enables investors to understand the level of risk associated with the Fund and whether the asset allocation is in line with the Fund’s risk framework.Equity Exposure (% of total AUM)
Data as of: 31 Jan 2025.- Equity Investment Rate
- Equity Exposure
Capitalisation Breakdown
The capitalisation breakdown refers to the distribution of the Fund's investments according to the size of the companies in which it invests. It indicates in which capitalisation categories (small, medium or large) the Fund allocates its capital.Capitalisation Breakdown
Data as of: 31 Jan 2025.Equity Derivatives
This table lists all the equity derivatives in the portfolio. It shows the underlying assets to which the fund is exposed and the fund's position (long or short) on each of these underlyings.Equity Derivatives
Data as of: 7 Feb 2025.| Equity derivatives | ||
| ESTX BNK € PR | ||
| EURO STOXX 50 PR | ||
| NASDAQ 100 STOCK INDX | ||
| S&P 500 INDEX | ||
| STXE 600 € PR | ||
| STXE 600 HECR € PR | ||
| STXE 600 IG&S € PR |
Total (Long + Short)
-66.8 %
Did you enjoy the fund page?
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
The Fund is a common fund in contractual form (FCP) conforming to the UCITS Directive under French law.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.